Article info
PDFOriginal research
Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population
- Correspondence to Dr Shalini Shah, Department of Anesthesiology & Perioperative Care, University of California Irvine Health, Orange, California, USA; ssshah1{at}hs.uci.edu
Citation
Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population
Publication history
- Received April 23, 2020
- Revision received September 11, 2020
- Accepted September 15, 2020
- First published October 26, 2020.
Article Versions
- You are currently viewing a Previous version of this article (11 December 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Society of Regional Anesthesia & Pain Medicine 2020. No commercial re-use. See rights and permissions. Published by BMJ.